Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Alembic Pharmaceuticals Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (367)
ARTG (148)
Prescription medicine registration (10)

Date

2025 (83)
2024 (10)
2023 (249)
2022 (10)
2021 (84)
2020 (22)
2019 (2)
2018 (17)
2017 (17)
2016 (3)
2015 (11)
2013 (11)
2012 (6)

Search

Sponsor content

525 result(s) found, displaying 281 to 290

ARIVEL ARIPIPRAZOLE aripiprazole 30 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
PIVELON ARIPIPRAZOLE aripiprazole 15 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VICOMAT lacosamide 50 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
LACOSAMIDE AGHL lacosamide 100 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VICOMAT lacosamide 100 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
LACOSAMIDE AGHL lacosamide 200 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
LACOSAMIDE APPL lacosamide 150 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
LACOSAMIDE APL lacosamide 100 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
LACOSAMIDE AGHL lacosamide 50 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VIMOLAC lacosamide 50 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd

Pages

First page
Previous page
…
Page 25
Page 26
Page 27
Page 28
Current page 29
Page 30
Page 31
Page 32
Page 33
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.